Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Uni-Bio Science GroupUNBSF 58 Median PS Value is $0.02 as of Aug. 20, 2026, which is 96% below its 10-year median of 0.48. GuruFocus rates UNBSF with a GF Score™ of 58/100 and a GF Value™ of $0.01. The stock has 3 warning signs investors should review. Among 279 Biotechnology companies, Uni-Bio Science Group ranks better than 88.17% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Uni-Bio Science Group (OTCPK:UNBSF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Uni-Bio Science Group's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.004
/
0.02
=
0.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Uni-Bio Science Group Median PS Value Related Terms
Uni-Bio Science Group Median PS Value Historical Data
* Premium members only.
The historical data trend for Uni-Bio Science Group's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UNBSF vs VRTX, REGN, RVMD: Median PS Value Comparison
For the Biotechnology subindustry, Uni-Bio Science Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uni-Bio Science Group Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Uni-Bio Science Group's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.5385.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Uni-Bio Science Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.013.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Uni-Bio Science Group (UNBSF) has a Median PS Value of $0.02 as of Aug. 20, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Uni-Bio Science Group and its competitors. This is 96% below median its historical median of 0.48. Over the past decade, Uni-Bio Science Group's Median PS Value has ranged from 0.18 to 0.75. According to the industry distribution chart, Uni-Bio Science Group ranks #33 out of 279 companies in the Biotechnology industry, placing it in the top 11.8%.
Is Uni-Bio Science Group's Median PS Value too high?
Uni-Bio Science Group's current Median PS Value of $0.02 is 96% below median its 10-year median of 0.48. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 0.75. The Biotechnology industry median Median PS Value is 0.63. Uni-Bio Science Group's value of $0.02 is 96.8% below this industry median. Based on the distribution chart, Uni-Bio Science Group ranks #33 out of 279 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Uni-Bio Science Group has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Uni-Bio Science Group's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Uni-Bio Science Group ranks #33 out of 279 companies for Median PS Value. This places Uni-Bio Science Group in the top 12% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.63. Uni-Bio Science Group's value of $0.02 is 96.8% below this benchmark. Historically, Uni-Bio Science Group's own Median PS Value has ranged from 0.18 to 0.75 over the past decade. While the company's 10-year median is 0.48 vs. the industry median of 0.63, Uni-Bio Science Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 279 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Uni-Bio Science Group's current Median PS Value of $0.02 is 96.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Uni-Bio Science Group and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uni-Bio Science Group's current Median PS Value is $0.02, which is 96% below median its own 10-year median of 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uni-Bio Science Group stock overvalued right now?
Uni-Bio Science Group (UNBSF) has a current Median PS Value of $0.02. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 60% below its estimated fair value. The current Median PS Value is $0.02, which is 96% below median its 10-year median of 0.48 and 96.8% below the Biotechnology industry median of 0.63. Uni-Bio Science Group's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Uni-Bio Science Group (UNBSF), the current Median PS Value is $0.02 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uni-Bio Science Group (UNBSF) Overvalued in 2026?
Based on GuruFocus' analysis, Uni-Bio Science Group stock appears to be undervalued.
The current stock price of $0.00 is trading 60% below its estimated GF Value™ of $0.01.
Key valuation signals for UNBSF:
Median PS Value: $0.02 (96% below median its 10-year median of 0.48)
GF Value™: $0.01 vs. price of $0.00 (60% below fair value)
Industry Position: 96.8% below the Biotechnology median (#33 of 279)
No single metric tells the full story. See the UNBSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
58GF Score
Get the complete analysis for UNBSF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UNBSF has been successfully added to your 
